Augusta University
Patients with a high number of genes most associated with pathways that lead to cell death in lung cancer are at increased risk of dying early from their disease, researchers report.
Learn how a researcher at the Georgia Cancer Center is working to eliminate Georgia's breast cancer disparities.
Georgia Cancer Center researcher tackles clinical trial hesitancy in the Black community in the southeast.
$1.8 million NCI grant enables exploration of cancer-fighting compound isolated from Moroccan fungus
MCG and Georgia Cancer Center scientists have early evidence that the peptide EnnA, isolated from a fungus living symbiotically with a flowering plant known for its penchant of trapping flies, could be a powerful opponent of aggressive triple...
The American Cancer Society and Pfizer have awarded over $399,000 to the Georgia Cancer Center as part of a grant program focused on reducing racial disparities and helping optimize cancer outcomes for Black men and women.
Identifying more genetic mutations in an individual’s cancer enables more targeted treatment for patients. That includes finding mutations not previously associated with their cancer type, which opens the door to using drugs targeting those...
A new method that produces a better tumor profile is particularly adept at recognizing some of the most serious gliomas, the most common brain tumor type in adults.
A group of scientists at the Georgia Cancer Center of Augusta University recently reported that CAR T cells can stay active longer and mediate tumor killing more effectively when STAT5, a key signaling molecule, is kept in an active form within CAR...
Aggressive colorectal cancers set up an interactive network of checkpoints to keep the immune system at bay, scientists report.
In the early part of the last century, blood transfusions occurred directly from the donor to patient. Virgil Sydenstricker found a better way, and it's still in use today.
There appears to be an unhealthy synergy between mental illness and prostate cancer, and researchers are working to dissect the relationship by first assembling the largest dataset ever of veterans with either condition or both.
While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome and best treatment options, scientists found that sophisticated new subtyping techniques designed...
